Informa (LON:INF) Stock Price Crosses Above Two Hundred Day Moving Average – Here’s Why

Informa plc (LON:INF)’s stock price crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 832.79 and traded as high as GBX 884.80. Informa shares last traded at GBX 879.08, with a volume of 2,800,884 shares traded.

Analysts Set New Price Targets

A number of research firms have recently issued reports on INF. Citigroup lowered their price objective on Informa from GBX 1,000 to GBX 850 and set a “neutral” rating on the stock in a research report on Thursday, April 9th. JPMorgan Chase & Co. decreased their price target on shares of Informa from GBX 1,300 to GBX 1,285 and set an “overweight” rating on the stock in a research note on Thursday, July 2nd. Five investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat, Informa currently has a consensus rating of “Moderate Buy” and an average price target of GBX 1,093.33.

Informa Stock Up 0.2%

The business’s 50 day moving average price is GBX 850.09 and its 200-day moving average price is GBX 832.79. The company has a debt-to-equity ratio of 61.56, a current ratio of 0.44 and a quick ratio of 1.70. The company has a market cap of £11.02 billion, a P/E ratio of 1,098.85, a PEG ratio of 0.75 and a beta of 0.69.

Insiders Place Their Bets

In other Informa news, insider Gareth Wright purchased 222 shares of the company’s stock in a transaction that occurred on Wednesday, May 20th. The stock was purchased at an average cost of GBX 809 per share, with a total value of £1,795.98. Also, insider Stephen A. Carter acquired 222 shares of Informa stock in a transaction on Wednesday, May 20th. The stock was acquired at an average cost of GBX 809 per share, for a total transaction of £1,795.98. Company insiders own 0.39% of the company’s stock.

About Informa

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.

And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.